Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
Conditions
- Advanced Solid Tumors
- Head and Neck Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Renal Cell Carcinoma
- Malignant Glioma
- Non-small Cell Lung Cancer
Interventions
- BIOLOGICAL: Cabiralizumab
- BIOLOGICAL: Nivolumab
Sponsor
Five Prime Therapeutics, Inc.
Collaborators